BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8365797)

  • 1. Role of prostaglandins in congenital heart disease.
    Yadav S; Khalil A
    Indian Pediatr; 1993 Mar; 30(3):387-91. PubMed ID: 8365797
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostaglandins and the perinatal period].
    Maragno I; Alitto F; Santostasi G; Sandri R; Neri G; Dorigo P
    Minerva Cardioangiol; 1987 Apr; 35(4):183-92. PubMed ID: 3601107
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prostaglandin treatment of ductus-dependent congenital heart defects].
    Olsson B; Björkhem G; Lundström NR
    Lakartidningen; 1984 Oct; 81(40):3619-22. PubMed ID: 6541738
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostaglandins and the management of congenital heart disease.
    Taylor WJ; Alpert BS
    Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comments on the pharmacologic manipulation of the ductus arteriosus in newborns.
    Rowe RD
    Adv Prostaglandin Thromboxane Res; 1978; 4():383-5. PubMed ID: 645513
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical use of prostaglandins and prostaglandin synthetase inhibitors in cardiac problems of the newborn.
    Olley PM; Coceani F; Rowe RD; Swyer PR
    Adv Prostaglandin Thromboxane Res; 1980; 7():913-6. PubMed ID: 6768235
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of ductus-dependent congenital heart diseases with prostaglandin E1].
    Lillquist K
    Ugeskr Laeger; 1979 Jul; 141(28):1915-6. PubMed ID: 473414
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostaglandin treatment of newborns with ductal-dependent congenital heart disease.
    Linday LA; Engle MA
    Pediatr Ann; 1981 Apr; 10(4):29-38. PubMed ID: 7232040
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prolonged prostaglandin E-1 therapy of newborn infants with congenital heart defects].
    Kertész E; Hencz P; Tekulics P; Beviz J; Száva J; Matkó I; Kovács G
    Orv Hetil; 1980 May; 121(20):1197-9. PubMed ID: 7413203
    [No Abstract]   [Full Text] [Related]  

  • 10. Neonatal manipulation: patent ductus arteriosus.
    Heymann MA; Rudolph AM
    Cardiovasc Clin; 1981; 11(2):301-10. PubMed ID: 7011547
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prostaglandin E1 in newborn infants with ductus-dependent heart diseases. Review of 40 cases].
    Simões LC; Sarachaga IH; Quero M; Casanova M; Cazzaniga M; Villibre D
    Arq Bras Cardiol; 1985 Jul; 45(1):31-6. PubMed ID: 3938651
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of prostaglandins in duct-dependent congenital heart conditions.
    Singh Y; Mikrou P
    Arch Dis Child Educ Pract Ed; 2018 Jun; 103(3):137-140. PubMed ID: 29162633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of prostaglandins in cardiopulmonary diseases of the newborn.
    Olley PM; Coceani F
    Semin Perinatol; 1980 Apr; 4(2):135-41. PubMed ID: 6990504
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prostaglandins and the treatment of congenital heart defects].
    Sharykin AS
    Pediatriia; 1981 Mar; (3):66-8. PubMed ID: 7012780
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analogs of prostaglandin-related substances and inhibitors of their formation and metabolism. Clinical application to the pediatric field--arteries and prostaglandins].
    Honda S
    Nihon Rinsho; 1985 Mar; 43(3):603-7. PubMed ID: 3892092
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostaglandin E1 in the neonate with heart disease.
    Schleman MM; Casta A; Mongkolsmai C; Black IF
    Adv Prostaglandin Thromboxane Res; 1980; 7():879-81. PubMed ID: 7369051
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral administration of prostaglandin E2 in the hypoplastic left heart syndrome.
    Fujiseki Y; Yamamoto H; Hattori M; Yamawaki Y; Goto M; Shimada M
    Jpn Heart J; 1983 May; 24(3):481-7. PubMed ID: 6576179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects.
    Tálosi G; Katona M; Rácz K; Kertész E; Onozó B; Túri S
    J Perinat Med; 2004; 32(4):368-74. PubMed ID: 15346826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congenital heart disease with ductus dependent systemic blood flow].
    Yasuda T; Tauchi N; Nagashima M
    Ryoikibetsu Shokogun Shirizu; 1996; (13):228-31. PubMed ID: 9117611
    [No Abstract]   [Full Text] [Related]  

  • 20. Arachidonic acid derivatives in the perinatal period.
    Heymann MA
    Adv Pediatr; 1989; 36():151-75. PubMed ID: 2506749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.